Swiss aesthetic manufacturer Teoxane hosted a Teolabs training event for 40 delegates at the Cosmed Aesthetic Training Academy, Dublin on November 7.
An article published in the Aesthetic Surgery Journal Open Forum, authored by McGuire et al., has developed a series of questions and answers that plastic surgeons can use in the management of asymptomatic patients with textures surface breast implants.
A study published in JAMA Facial Plastic Surgery suggests that facial bones in black adults maintain higher mineral density as they age than other races, resulting in fewer changes to other facial structures.
The British Association of Aesthetic Plastic Surgeons (BAAPS), the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) and the Plastic Surgery Trainees Association (PLASTA) have released a joint statement for trainees in plastic surgery undertaking non-surgical injectable treatments.
A new study by the Aesthetic Surgery Journal has found that using a smartphone for post-operative follow-ups and taking ‘selfies’, improved patients’ experience and helped to detect early complications.
The British Association of Sclerotherapists (BAS) will hold its annual meeting on May 18 at the Dorney Lake Conference Centre in Windsor.
The Royal College of Surgeons (RCS) has launched a new system of certification with the aim of making the cosmetic surgery sector safer for patients.
Leading industry professionals are to hold a five-day conference on surgical and non-surgical procedures for the face.
Last month the CEN aesthetic surgery draft standard was approved for publication as a European standard. Sharon Bennett, the UK lead on BSI/CEN non-surgical medical cosmetic standards gives us an update on the latest developments. "What does this mean to us as cosmetic medical practitioners? Essentially not much – the standard only addresses surgical procedures, as the non-surgical content has been removed in anticipation of a separate draft standard.
Pharma giant Johnson & Johnson has revealed that it will discontinue developments of PurTox, a neurotoxin widely referred to as a potential rival for Allergan’s Botox.